-
The Puzzle of Pancreatic Cancer
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
-
Caregiving With Confidence
Strategies for Effective CommunicationWhen families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
-
Get Involved
Filling a VoidA mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.
by Elizabeth Rosto Sitko
-
Advocacy in Action
Leaving a LegacyTwo mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
-
A Unified Strategy
A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.
by Marci A. Landsmann
-
Forward Look
More Options to Prevent Blood Clots in High-Risk Cancer PatientsUpdated guidelines support use of oral blood thinners.
by Jane Langille
-
Survivor Profile
A Driving ForceMark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
-
Forward Look
New Guidelines for Radiation Therapy in Pancreatic CancerRecommendations address conflicts and research gaps.
by Ashley P. Taylor
-
Medicare Coverage for Next-Generation Sequencing Tests
Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
Cancer Talk
Most Cancer Survivors Don’t Meet Healthy Diet Goals
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon